Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2012-09-06 21:03:17 UTC |
---|
Update Date | 2022-09-22 18:34:22 UTC |
---|
HMDB ID | HMDB0028995 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Phenylalanylglycine |
---|
Description | Phenylalanylglycine is a dipeptide composed of phenylalanine and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. |
---|
Structure | N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O InChI=1S/C11H14N2O3/c12-9(11(16)13-7-10(14)15)6-8-4-2-1-3-5-8/h1-5,9H,6-7,12H2,(H,13,16)(H,14,15)/t9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
F-G | ChEBI | FG | ChEBI | L-Phe-gly | ChEBI | F-g Dipeptide | HMDB | FG Dipeptide | HMDB | L-Phenylalanylglycine | HMDB | N-L-Phenylalanylglycine | HMDB | N-Phenylalanylglycine | HMDB | Phe-gly | HMDB | Phenylalanine glycine dipeptide | HMDB | Phenylalanine-glycine dipeptide | HMDB | Phenylalanyl-glycine | HMDB | Phenylalanylglycine | ChEBI |
|
---|
Chemical Formula | C11H14N2O3 |
---|
Average Molecular Weight | 222.244 |
---|
Monoisotopic Molecular Weight | 222.100442319 |
---|
IUPAC Name | 2-[(2S)-2-amino-3-phenylpropanamido]acetic acid |
---|
Traditional Name | [(2S)-2-amino-3-phenylpropanamido]acetic acid |
---|
CAS Registry Number | 721-90-4 |
---|
SMILES | N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O |
---|
InChI Identifier | InChI=1S/C11H14N2O3/c12-9(11(16)13-7-10(14)15)6-8-4-2-1-3-5-8/h1-5,9H,6-7,12H2,(H,13,16)(H,14,15)/t9-/m0/s1 |
---|
InChI Key | GLUBLISJVJFHQS-VIFPVBQESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- Phenylalanine or derivatives
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- Aralkylamine
- Monocyclic benzene moiety
- Fatty amide
- Fatty acyl
- Benzenoid
- Amino acid or derivatives
- Carboxamide group
- Carboxylic acid salt
- Amino acid
- Secondary carboxylic acid amide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic salt
- Hydrocarbon derivative
- Primary aliphatic amine
- Organic nitrogen compound
- Amine
- Organic oxygen compound
- Carbonyl group
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Organopnictogen compound
- Organic zwitterion
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -2.29 | Extrapolated |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 150.043 | 30932474 | DeepCCS | [M-H]- | 147.648 | 30932474 | DeepCCS | [M-2H]- | 180.763 | 30932474 | DeepCCS | [M+Na]+ | 155.956 | 30932474 |
Predicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.97 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 9.6127 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.37 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 193.7 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 871.2 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 253.5 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 102.4 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 170.1 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 84.1 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 270.7 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 306.0 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 648.5 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 698.5 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 267.5 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 859.7 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.4 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 231.3 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 390.4 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 370.7 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 117.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Phenylalanylglycine,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 | 2135.5 | Semi standard non polar | 33892256 | Phenylalanylglycine,1TMS,isomer #2 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O | 2164.8 | Semi standard non polar | 33892256 | Phenylalanylglycine,1TMS,isomer #3 | C[Si](C)(C)N(CC(=O)O)C(=O)[C@@H](N)CC1=CC=CC=C1 | 2105.3 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O[Si](C)(C)C | 2151.3 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O[Si](C)(C)C | 2131.0 | Standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CN(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C | 2074.4 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #2 | C[Si](C)(C)OC(=O)CN(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C | 2148.1 | Standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #3 | C[Si](C)(C)N([C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)[Si](C)(C)C | 2310.7 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #3 | C[Si](C)(C)N([C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)[Si](C)(C)C | 2158.4 | Standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #4 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O)[Si](C)(C)C | 2161.3 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TMS,isomer #4 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O)[Si](C)(C)C | 2166.8 | Standard non polar | 33892256 | Phenylalanylglycine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 2269.2 | Semi standard non polar | 33892256 | Phenylalanylglycine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 2241.6 | Standard non polar | 33892256 | Phenylalanylglycine,3TMS,isomer #2 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2111.1 | Semi standard non polar | 33892256 | Phenylalanylglycine,3TMS,isomer #2 | C[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2212.2 | Standard non polar | 33892256 | Phenylalanylglycine,3TMS,isomer #3 | C[Si](C)(C)N(CC(=O)O)C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 2267.2 | Semi standard non polar | 33892256 | Phenylalanylglycine,3TMS,isomer #3 | C[Si](C)(C)N(CC(=O)O)C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 2293.2 | Standard non polar | 33892256 | Phenylalanylglycine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2295.4 | Semi standard non polar | 33892256 | Phenylalanylglycine,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CN(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2334.5 | Standard non polar | 33892256 | Phenylalanylglycine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 | 2389.7 | Semi standard non polar | 33892256 | Phenylalanylglycine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O | 2385.9 | Semi standard non polar | 33892256 | Phenylalanylglycine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(CC(=O)O)C(=O)[C@@H](N)CC1=CC=CC=C1 | 2348.2 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C | 2609.8 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O[Si](C)(C)C(C)(C)C | 2527.8 | Standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2587.6 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)[C@@H](N)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 2554.3 | Standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)[Si](C)(C)C(C)(C)C | 2754.3 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)[Si](C)(C)C(C)(C)C | 2546.8 | Standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C | 2621.4 | Semi standard non polar | 33892256 | Phenylalanylglycine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C | 2558.9 | Standard non polar | 33892256 | Phenylalanylglycine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2967.0 | Semi standard non polar | 33892256 | Phenylalanylglycine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2798.3 | Standard non polar | 33892256 | Phenylalanylglycine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2815.5 | Semi standard non polar | 33892256 | Phenylalanylglycine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC=CC=C1)C(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2780.8 | Standard non polar | 33892256 | Phenylalanylglycine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(CC(=O)O)C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2957.8 | Semi standard non polar | 33892256 | Phenylalanylglycine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N(CC(=O)O)C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2835.2 | Standard non polar | 33892256 | Phenylalanylglycine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3153.8 | Semi standard non polar | 33892256 | Phenylalanylglycine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CN(C(=O)[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3049.0 | Standard non polar | 33892256 |
|
---|
Disease References | Colorectal cancer |
---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
General References | - Pingitore F, Wesdemiotis C: Characterization of dipeptide isomers by tandem mass spectrometry of their mono- versus dilithiated complexes. Anal Chem. 2005 Mar 15;77(6):1796-806. [PubMed:15762588 ]
- Thirumoorthy K, Soni K, Nandi N: The molecular recognition of dipeptide by oligoglycyl head group of amphiphile: a quantum chemical study. J Nanosci Nanotechnol. 2009 Jan;9(1):77-89. [PubMed:19441281 ]
- Epand RM: Virus replication inhibitory peptide inhibits the conversion of phospholipid bilayers to the hexagonal phase. Biosci Rep. 1986 Jul;6(7):647-53. [PubMed:3779040 ]
- Storer AC, Angus RH, Carey PR: Comparison of the kinetics of the papain-catalyzed hydrolysis of glycine- and alanine-based esters and thiono esters. Biochemistry. 1988 Jan 12;27(1):264-8. [PubMed:3349032 ]
- Li L, Zheng LX, Yang FY: Effect of propensity of hexagonal II phase formation on the activity of mitochondrial ubiquinol-cytochrome c reductase and H(+)-ATPase. Chem Phys Lipids. 1995 Jun 19;76(2):135-44. [PubMed:7634362 ]
- Ningsih F, Kitani S, Fukushima E, Nihira T: VisG is essential for biosynthesis of virginiamycin S, a streptogramin type B antibiotic, as a provider of the nonproteinogenic amino acid phenylglycine. Microbiology. 2011 Nov;157(Pt 11):3213-20. doi: 10.1099/mic.0.050203-0. Epub 2011 Aug 4. [PubMed:21816878 ]
- Kruger RG, Lu W, Oberthur M, Tao J, Kahne D, Walsh CT: Tailoring of glycopeptide scaffolds by the acyltransferases from the teicoplanin and A-40,926 biosynthetic operons. Chem Biol. 2005 Jan;12(1):131-40. [PubMed:15664522 ]
- Makowski M, Lisowski M, Maciag A, Wiktor M, Szlachcic A, Lis T: Two pentadehydropeptides with different configurations of the DeltaPhe residues. Acta Crystallogr C. 2010 Mar;66(Pt 3):o119-23. doi: 10.1107/S0108270110003094. Epub 2010 Feb 3. [PubMed:20203407 ]
- Fujita T, Morishita Y, Ito H, Kuribayashi D, Yamamoto A, Muranishi S: Enhancement of the small intestinal uptake of phenylalanylglycine via a H+/oligopeptide transport system by chemical modification with fatty acids. Life Sci. 1997;61(25):2455-65. [PubMed:9416764 ]
- Yeagle PL, Young J, Hui SW, Epand RM: On the mechanism of inhibition of viral and vesicle membrane fusion by carbobenzoxy-D-phenylalanyl-L-phenylalanylglycine. Biochemistry. 1992 Mar 31;31(12):3177-83. [PubMed:1554703 ]
- Varela AS, Bosco Lopez Saez JJ: Utility of serum activity of angiotensin-converting enzyme as a tumor marker. Oncology. 1993 Nov-Dec;50(6):430-5. [PubMed:8233282 ]
- Wang P, Polce MJ, Ohanessian G, Wesdemiotis C: The sodium ion affinities of cytosine and its methylated derivatives. J Mass Spectrom. 2008 Apr;43(4):485-94. [PubMed:17994645 ]
- Andersson LI, Muller R, Vlatakis G, Mosbach K: Mimics of the binding sites of opioid receptors obtained by molecular imprinting of enkephalin and morphine. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4788-92. [PubMed:7761401 ]
- Mizuma T, Masubuchi S, Awazu S: Intestinal absorption of stable cyclic glycylphenylalanine: comparison with the linear form. J Pharm Pharmacol. 1997 Nov;49(11):1067-71. [PubMed:9401939 ]
- Ram S, Buchsbaum DJ: Synthesis of a new class of isothiocyanatopeptide bifunctional chelating agents for coupling to monoclonal antibodies. Int J Pept Protein Res. 1996 Jul;48(1):79-86. [PubMed:8844266 ]
- Yeagle PL, Dentino AR, Smith FT, Spooner P, Watts A: The antiviral peptide carbobenzoxy-D-phenylalanyl-L-phenylalanylglycine changes the average conformation of phospholipids in membranes. Biochemistry. 1993 Nov 16;32(45):12197-202. [PubMed:8218297 ]
- Kelsey DR, Flanagan TD, Young JE, Yeagle PL: Inhibition of Sendai virus fusion with phospholipid vesicles and human erythrocyte membranes by hydrophobic peptides. Virology. 1991 Jun;182(2):690-702. [PubMed:1850923 ]
- Kelsey DR, Flanagan TD, Young J, Yeagle PL: Peptide inhibitors of enveloped virus infection inhibit phospholipid vesicle fusion and Sendai virus fusion with phospholipid vesicles. J Biol Chem. 1990 Jul 25;265(21):12178-83. [PubMed:2165053 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|